Hong Kong, China vs Mauritania: Tuberculosis patients living with HIV receiving antiretroviral therapy

Hong Kong, China
27 patients
in 2021
Mauritania
21 patients
in 2021
Hong Kong, China rank
96th
Mauritania rank
99th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Hong Kong, China
  • Mauritania
0204060200320122021

How they compare

Hong Kong, China currently reports 27 patients against 21 patients in Mauritania, a difference of 6 patients.

That makes Hong Kong, China's figure about 1.3 times Mauritania's.

The two have swapped places 4 times across 8 shared years of data; in 2005 it was Hong Kong, China ahead.

Hong Kong, China ranks 96th and Mauritania ranks 99th of 183 countries.

Mauritania has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Hong Kong, China Mauritania Difference Ahead
2000s 20.67 patients 35.33 patients 14.67 patients Mauritania
2010s 10.33 patients 27.67 patients 17.33 patients Mauritania
2020s 17.5 patients 36 patients 18.5 patients Mauritania

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Hong Kong, China or Mauritania?
Hong Kong, China, at 27 patients against 21 patients in Mauritania as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Hong Kong, China and Mauritania?
6 patients, with Hong Kong, China ahead.
How many years of comparable data are there for Hong Kong, China and Mauritania?
8 years are reported by both, from 2005 to 2021.
How do Hong Kong, China and Mauritania rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Hong Kong, China ranks 96th and Mauritania ranks 99th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hong Kong, China vs Mauritania: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 16 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/mauritania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/mauritania/">Hong Kong, China vs Mauritania: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.